Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 291.80
+10.35 (3.68%)
At close: Mar 25, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 29.26 billion as of March 27, 2026. Its market cap has decreased by -14.72% in one year.
Market Cap
29.26B
Enterprise Value
32.07B
Revenue
8.97B
Ranking
n/a
PE Ratio
58.51
Stock Price
291.80
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 29.26B, an increase of 8,093.64%. That is a compound annual growth rate of 19.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 29.26B | -13.35% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 53.75B |
| Bliss GVS Pharma | 23.66B |
| Novartis India | 23.14B |
| Unichem Laboratories | 21.05B |
| Morepen Laboratories | 20.26B |
| Hikal | 19.97B |
| Kwality Pharmaceuticals | 15.11B |
| Amrutanjan Health Care | 14.94B |